|
⚲
|
| Keyboard |
| Lyons Gary A
✚
|
|
|---|---|
| CIK # | 0001123343 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001123343] | |
| 4 | [0001123343] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-12-03 | Sell | 15,000 | $152.61 | 2,289,150 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-12-03 | Option exercise | 15,000 | $47.89 | 718,350 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2025-12-03 | Option exercise | 15,000 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2025-05-22 | Option exercise | 1,435 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-05-22 | Option exercise | 1,435 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-05-21 | Grant | 1,659 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2025-05-21 | Grant | 3,305 | $0.00 | |
|
Travere Therapeutics Inc TVTX
Stock option (right to buy) · derivative
|
2025-05-15 | Grant | 19,500 | $0.00 | |
|
Travere Therapeutics Inc TVTX
Common Stock
|
2025-05-15 | Grant | 6,500 | $0.00 | |
|
Travere Therapeutics Inc TVTX
Common Stock
|
2024-10-04 | Sell | 18,821 | $15.15 | 285,138 |
|
Travere Therapeutics Inc TVTX
Common Stock
|
2024-10-04 | Option exercise | 40,000 | $10.48 | 419,200 |
|
Travere Therapeutics Inc TVTX
Common Stock
|
2024-10-04 | Sell | 21,179 | $14.35 | 303,919 |
|
Travere Therapeutics Inc TVTX
Stock option (right to buy) · derivative
|
2024-10-04 | Option exercise | 40,000 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-08-13 | Option exercise | 11,570 | $42.76 | 494,733 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-08-13 | Sell | 11,570 | $150.43 | 1,740,475 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2024-08-13 | Option exercise | 11,570 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-07-16 | Option exercise | 930 | $42.76 | 39,767 |
|
Neurocrine Biosciences Inc NBIX
Common Stock
|
2024-07-16 | Sell | 930 | $150.03 | 139,528 |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2024-07-16 | Option exercise | 930 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Non-Qualified Stock Option · derivative
|
2024-05-22 | Grant | 2,982 | $0.00 | |
| showing 20 of 197 most recent transactions | |||||